Company Filing History:
Years Active: 2002-2003
Title: Margret Hoehe: Innovator in Genomic Research
Introduction
Margret Hoehe is a distinguished inventor based in Berlin, Germany. He has made significant contributions to the field of genomic research, particularly in the study of the human μ-opioid receptor gene. With a total of 2 patents, Hoehe's work has advanced our understanding of genetic variations and their implications.
Latest Patents
Hoehe's latest patents include groundbreaking inventions. The first patent focuses on the genomic sequence of the human μ-opioid receptor gene and its variants, polymorphisms, and mutations. This invention is crucial for understanding the genetic factors that influence opioid response. The second patent presents a novel method for non-radioactive detection of membrane-bonded nucleic acids. This method encompasses various nucleic acids, including those containing single nucleotide polymorphisms (SNPs) and DNA arrays. Additionally, it includes a test kit designed to facilitate this detection method.
Career Highlights
Throughout his career, Hoehe has worked with prominent organizations. He has been associated with the Max Delbrück Center for Molecular Medicine, where he contributed to significant research initiatives. Additionally, he has worked with Genprofile AG, further enhancing his expertise in genomic technologies.
Collaborations
Hoehe has collaborated with notable colleagues in his field, including Birgit Wendel and Sebastian Delbruck. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Margret Hoehe's contributions to genomic research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in understanding genetic variations and their applications in medicine.